FdaApplication
NDA 020711
Identifiers
- fda_app_no: NDA020711
Properties
| Property | Value |
|---|---|
| applicant_name | GLAXOSMITHKLINE |
| application_type | NDA |
| approval_date | 1997-05-14 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ZYBAN | BUPROPION HYDROCHLORIDE | 100MG | TABLET, EXTENDED RELEASE;ORAL |
| ZYBAN | BUPROPION HYDROCHLORIDE | 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE;ORAL |
2 products